Gunma University Initiative for Advanced Research > News > Research > Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study (Karolinska Institute)

NEWS

Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study (Karolinska Institute)

An original research article “Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study” from Wheelock laboratory was published in European Respiratory Journal (IF 16.67).

 

■Title

Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study

 

Stacey N. Reinke1,2, Shama Naz1, Romanas Chaleckis1,3, Hector Gallart-Ayala1, Johan Kolmert1,4, Nazanin Z. Kermani 5, Angelica Tiotiu5,6, David I. Broadhurst 2, Anders Lundqvist 7, Henric Olsson 8, Marika Ström9,10, Åsa M. Wheelock9,10, Cristina Gómez 1,4, Magnus Ericsson 11, Ana R. Sousa 12, John H. Riley 12, Stewart Bates 12, James Scholfield 13, Matthew Loza 14, Frédéric Baribaud 14, Per S. Bakke 15, Massimo Caruso16, Pascal Chanez 17, Stephen J. Fowler18, Thomas Geiser 19, Peter Howarth 13, Ildikó Horváth 20, Norbert Krug 21, Paolo Montuschi 22, Annelie Behndig 23, Florian Singer 24, Jacek Musial 25, Dominick E. Shaw 26, Barbro Dahlén 10, Sile Hu 27, Jessica Lasky-Su 28, Peter J. Sterk 29, Kian Fan Chung 5, Ratko Djukanovic 13, Sven-ErikDahlén 4,10, Ian M. Adcock 5, *Craig E. Wheelock1,3,10, on behalf of the U-BIOPRED Study Group

 

■Journal

European Respiratory Journal (IF;16.67)

DOI: 10.1183/13993003.01733-2021

In press

 

■Link

https://erj.ersjournals.com/content/early/2021/11/04/13993003.01733-2021

トップへ戻る